跳至主要内容
临床试验/JPRN-UMIN000009553
JPRN-UMIN000009553已完成未知

Comparison of anti-inflammatory effects of rivaroxaban versus dabigatran in patients with non-valvular atrial fibrillation (RIVAL-AF study) -Multicenter randomized study- - Anti-inflammatory effects of rivaroxaban versus dabigatran

Division of Cardiology, Yokohama City University Medical Center0 个研究点目标入组 200 人开始时间: 2012年12月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

There were no significant differences in the time courses of any inflammatory marker between rivaroxaban and dabigatran treatment in patients with AF.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)stroke or systemic embolism within 6 months before enrollment (2)acute coronary syndromes or peripheral artery disease within 6 months before enrollment (3)acute heart failure (4)severe chronic renal failure (creatinine clearance < 30mL/min.) (5)receiving dual antiplatelet therapy (6)patients with a body weight of 50kg or less (7)uncontrolled hypertention (8)active malignancy (9)patients undergoing surgery within 6 months before enrollment (10)collagen disease (11)infectious disease (12)patients who are planned to undergoing catheter ablation for atrial fibrillation (13)contraindication of rivaroxaban or dabigatran (14)patients who are not allowed to participate in the trial by judgement of the treating physician

研究者

发起方
Division of Cardiology, Yokohama City University Medical Center

相似试验